REG - hVIVO plc - 2014 Annual Report and Financial Statements <Origin Href="QuoteRef">HVO.L</Origin>

hVIVOAnnouncement

15/07/2015 14:37

RNS Number : 2784L
hVIVO plc
24 April 2015
For immediate release 2.00pm: 24 April 2015
HVIVO PLC
("hVIVO" or the "Company")
2014 Annual Report and Financial Statements
hVIVO plc (AIM: HVO), the pioneer of human challenge models of disease, is pleased to announce that its Annual Report and Financial Statements for the year ended 31 December 2014 is being posted to shareholders today. It will be available on the Company's website (http://hvivo.com/investors/financial-reports/) from 4.30 pm today.
For further information please contact:
hVIVO plc+44 207 756 1300
Kym Denny (Chief Executive Officer)
Graham Yeatman (Chief Financial & Business Officer) 
Media Enquiries+44 203 021 3933 / +44 7854 979 420
Colin Paterson (Director of Marketing, Communication and Public Relations)
 
Numis Securities Limited  +44 207 260 1000 
Michael Meade / Freddie Barnfield (Nominated Adviser)
James Black / Michael Burke (Corporate Broking)
Notes to Editors:
hVIVO plc ("hVIVO") is a life sciences company pioneering a technology platform of human disease models to accelerate drug development and discovery in respiratory and infectious diseases. Based in the UK, hVIVO has conducted over 40 clinical studies, involving more than 1950 volunteers for a range of leading industry, governmental and academic clients.

This information is provided by RNS
The company news service from the London Stock Exchange
  END
ACSPKQDQDBKDQQB